Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT04958434 · TERMINATED

Trial details

NCT number: NCT04958434
Sponsor: Suzhou Transcenta Therapeutics Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Cancers Metastatic Human Papillomavirus-Related Malignant Neoplasm

Start date: 2021-06-11
Primary completion: 2023-09-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.